newsLicence extension submission accepted for kidney disease treatment by EMAThe licence extension submission for Invokana and Vokanamet has been…27 August 2019 | By Rachael Harper (European Pharmaceutical Review)The licence extension submission for Invokana and Vokanamet has been accepted by the EMA.